Fernando Quevedo MD

PubMed

• 4 citations
  Genomic attributes of prostate cancer across primary and metastatic noncastrate and castrate resistant disease states: a next generation sequencing study of 183 patients.
  Surendra Dasari, Michael R McCarthy, Antonina A Wojcik, Beth A Pitel, Arpan Samaddar
  Prostate Cancer and Prostatic Diseases. 2024-02-27
• 1 citations
  The Impact of Metastasis Histopathology on Oncologic Outcomes for Patients With Surgically Resected Metastatic Renal Cell Carcinoma.
  Rodrigo Rodrigues Pessoa, Reza Nabavizadeh, Fernando Quevedo, Daniel D Joyce, Christine M Lohse
  The Journal of Urology. 2023-10-01
• 1 citations
  Dynamic assessment of serum chromogranin A and treatment response with abiraterone acetate in metastatic castration-resistant prostate cancer.
  Akeem R Lewis, Brian A Costello, Fernando Quevedo, Lance C Pagliaro, Cristobal Sanhueza
  The Prostate. 2023-05-01

Journal Articles

• Long-term Treatment Outcomes for Locally Advanced Esophageal Cancer: A Single-Institution Experience  
  Sio TT, Wilson ZC, Stauder MC, Bhatia S, Martenson JA, Quevedo JF, Schomas DA, Miller RC, Am J Clin Oncol, 5/1/2013
• Malignant perivascular epithelioid cell tumor of the uterus  
  Bleeker JS, Quevedo JF, Folpe AL, Rare Tumors, 1/1/2012
• "Malignant" perivascular epithelioid cell neoplasm: risk stratification and treatment strategies  
  Bleeker JS, Quevedo JF, Folpe AL, Sarcoma, 1/1/2012
• Pilot study of granulocyte-macrophage colony-stimulating factor and interleukin-2 as immune adjuvants for a melanoma peptide vaccine  
  Block MS, Suman VJ, Nevala WK, Kottschade LA, Creagan ET, Kaur JS, Quevedo JF, McWilliams RR, Markovic SN, Melanoma Res, 10/1/2011
• Intensity-modulated radiotherapy for squamous cell carcinoma of the anal canal: efficacy of a low daily dose to clinically negative regions  
  Call JA, Haddock MG, Quevedo JF, Larson DW, Miller RC, Radiat Oncol, 1/1/2011
• The prognostic value of clinical and pathologic factors in esophageal adenocarcinoma: a mayo cohort of 796 patients with extended follow-up after surgical resection  
  Yoon HH, Khan M, Shi Q, Cassivi SD, Wu TT, Quevedo JF, Burch PA, Sinicrope FA, Diasio RB, Mayo Clin Proc, 12/1/2010
• Adjuvant chemoradiotherapy for resected pancreas cancer  
  Iott M, Neben-Wittich M, Quevedo JF, Miller RC, World J Gastrointest Surg, 11/1/2010
• A single-institution experience with 491 cases of small bowel adenocarcinoma  
  Halfdanarson TR, McWilliams RR, Donohue JH, Quevedo JF, Am J Surg, 6/1/2010
• Untitled  
  Weroha SJ, Quevedo JF, Med Oncol, 6/1/2010
• Treatment of hormone-refractory prostate cancer, HRPC, remains challenging  
  Weroha SJ, Quevedo JF, Med Oncol, 6/1/2010
• The prognostic importance of pathologically involved celiac node metastases in node-positive patients with carcinoma of the distal esophagus or gastroesophageal juncti...  
  Schomas DA, Quevedo JF, Donahue JM, Nichols FC, Romero Y, Miller RC, Dis Esophagus, 4/1/2010
• Treatment for M1a cancer of the esophagus may not be largely palliative  
  Schomas DA, Miller RC, Quevedo JF, J Thorac Oncol, 2/1/2010
• Intraperitoneal treatment for peritoneal mucinous carcinomatosis of appendiceal origin after operative management: long-term follow-up of the Mayo Clinic experience  
  Schomas DA, Miller RC, Donohue JH, Gill S, Thurmes PJ, Haddock MG, Quevedo JF, Gunderson LL, Ann Surg, 4/1/2009
• Metastatic malignant melanoma G Ital  
  Markovic SN, Erickson LA, Flotte TJ, Kottschade LA, McWilliams RR, Jakub JW, Farley DR, Tran NV, Schild SE, Olivier KR, Vuk-Pavlovic S, Sekulic A, Weenig RH, Pulido JS..., Dermatol Venereol, 2/1/2009
• Angiosarcoma of the liver after multimodality therapy for gallbladder carcinoma  
  Botros M, Quevedo J, Miller RC, Radiology and Oncology, 1/1/2009
• Colorectal cancer patients with liver metastases and severe hyperbilirubinemia: A consecutive series that explores the benefits and risks of chemotherapy  
  Walia T, Quevedo JF, Hobday TJ, Croghan G, Jatoi A, Ther Clin Risk Manag, 12/1/2008
• Impact of endoscopic ultrasonography and physician specialty on the management of patients with esophagus cancer  
  Gines A, Cassivi SD, Martenson JA Jr, Schleck C, Deschamps C, Sinicrope FA, Alberts SR, Murray JA, Zinsmeister AR, Vazquez-Sequeiros E, Nichols FC 3rd, Miller RC, Quev..., Dis Esophagus, 1/1/2008
• Predictors of survival from urachal cancer: a Mayo Clinic study of 49 cases  
  Molina JR, Quevedo JF, Furth AF, Richardson RL, Zincke H, Burch PA, Cancer, 12/1/2007
• Small cell carcinoma of the urinary bladder – The Mayo Clinic experience  
  Choong NWW, Quevedo JF, Kaur JS, Cancer, 3/1/2005
• Investigating four 'myths' surrounding dysphagia in patients with metastatic esophageal cancer A multi-institutional study from the North Central Cancer Treatment Group  
  Jatoi A, Foster N, Johnson P, Klee G, Quevedo JF, Morton RF, Nair S, Kardinal CG, Mailliard JA, Dis Esophagus, 1/1/2004
• Thromboembolism in patients with high-grade glioma  
  Quevedo JF, Buckner JC, Schmidt JL, Dinapoli RP, O'Fallon JR, Mayo Clin Proc, 4/1/1994
• Pseudo hypoproteinemia in Multiple Myeloma  
  Avashia JH, Walsh TD, Valenzuela R, Quevedo JF, Cloud J, Cleveland Clinic Journal of Medicine, 1/1/1990
• Distribucion de los grupos sanguineos y proteinas sencas en habitants de Guayaquil y La Libertad, Provincia del Guayas  
  Nebel C, Weinauer P, Quevedo JF, Paredes L, Miscelaneas Antropologicas Ecuatorianes, 1/1/1985
• Join now to see all

Abstracts/Posters

• Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma (aBCC): 18-month update of the pivotal ERIVANCE BCC study.
  Aleksandar S, Migden M, Basset-Seguin N, Garbe C, Gesierich A, Lao C, Miller C, Mortier L, Murrell D, Hamid O, Quevedo JF, Mackey H, Schadendorf D, ASCO, 1/1/2013
• Concurrent chemotherapy and intensity modulated radiation therapy (IMRT) in the treatment of anal cancer: a retrospective review from a large academic center.
  Call J, Haddock M, Quevedo JF, David L, Miller R, American Journal Of Clinical Oncology-cancer Clinical Trials, 4/1/2011
• Down-staging of locally advanced prostate cancer with anti-CTLA-4 monoclonal antibody prior to radical prostatectomy.
  Granberg C, Thompson RH, Quevedo JF, Karnes RJ, Frank I, Kwon ED, Blute ML, J Clin Oncol, 5/1/2009
• Possible therapeutic reversal of immune suppression in patients with metastatic melanoma by timed delivery of temozolomide chemotherapy: A pilot study.
  Quevedo F, Ashdown ML, Suman VJ, Robinson A, Kottschade LA, Kaur JS, Creagan ET, McWilliams RR, Markovic SN, J Clin Oncol, 5/1/2009
• Review of treatment outcomes for esophageal cancer: the Mayo Clinic Experience.
  Bhatia S, Miller RC, Quevedo JF, Schomas DA, Haddock MG, Int J Radiat Oncol Biol Phys, 1/1/2008
• Positron emission tomography scanning and pathologic assessment of neoadjurvant chemoradiotherapy for esophageal cancer.
  Schomas DA, Peller PJ, Donahue JM, Nichols FC, Lowe V, Quevedo JF, Miller RC, Int J Radiat Oncol Biol Phys, 1/1/2008
• NCCTG phase II trial (N044J) of AZD2171 for patients with hepatocellular carcinoma (HCC)--interim review of toxicity. (Abstract 186).
  Alberts SR, Morlan BW, Kim GP, Pitot HC, Quevedo FJ, Dakhil SR, Gross HM, Merchan JR, Roberts LR, ASCO Gastrointestinal Cancer Symposium, 1/1/2007
• NCCTG Phase I/II Trial of gemcitabine and pemetrexed in patients biliary tract or gallbladder carcinoma - phase II results.
  Alberts S, Foster N, McWilliams R, Quevedo F, Marschke R, Kugler J, Friedman E, Jaslowski A, Sande J, ASCO GI Cancer Symposium, 1/1/2007
• Intraperitoneal treatment for peritoneal mucinous carcinomatosis of appendiceal origin after operative management: The Mayo clinic experience.
  Schomas DA, Miller RC, Gill S, Thurmes PJ, Haddock MG, Quevedo JF, Donohue JH, Int J Radiat Oncol Biol Phys, 1/1/2007
• NCCTG phase I/II trial (N9943) of gemcitabine and pemetrexed in patients with biliary tract or gallbladder carcinoma: phase II results. (Abstract 4578)
  McWilliams RR, Foster NR, Quevedo FJ, Marschke RF, Kugler JW, Friedman EL, Jaslowski AJ, Sande JR, Alberts SR, J Clin Oncol, 1/1/2007
• A Phase II trial of green tea for androgen-independent prostate cancer: A north Central Cancer Treatment Group (NCCTG) trial.
  Jatoi A, Dakhil S, Burch P, Mattar B, Sloan J, Fitch T, Novotny P, Camoriano J, Young C, Rowland K, Quevedo F, Tan W, Proc Annu Meet Am Assoc Cancer Res, 3/1/2002
• Join now to see all

Lectures

• Long-term Safety and Efficacy of Vismodegib in Patients With Advanced Basal Cell Carcinoma: Final Update (30-month) of the Pivotal ERIVANCE BCC Study. 
  Chicago, IL - 6/1/2014
• GU Cancers 
  Lima, Peru - 8/1/2012
• Colon Cancer 
  Cuenca, Ecuador - 7/1/2012
• Systemic Treatment Renal Cell Carcinoma 
  Guayaquil, Ecuador - 12/1/2011
• Systemic Treatment Metastatic Clear Cell Renal Cell Carcinoma 
  Santiago, Chile - 11/1/2011
• Adjuvant treatment for patients with rectal cancer. 
  Cusco, Peru - 8/1/2010
• Targeted therapy for patients with metastatic colon cancer 
  Cusco, Peru - 8/1/2010
• Review Seminoma 
  Rochester, MN - 4/1/2010
• Review Nonseminoma 
  Rochester, MN - 4/1/2010
• Review of Renal Cell Carcinoma 
  Rochester, MN - 11/1/2009
• Chemotherapy for Stage 4 Colon Cancer 
  Ecuador - 10/1/2009
• Treatment for Patients with Metastatic Renal Cell Carcinoma 
  Ecuador - 10/1/2009
• Update on Testicular Cancer 
  Amelia Island, FL - 8/1/2009
• Early stage colon and rectal cancer: Chemotherapy and Follow-up 
  Rochester, MN - 6/1/2009
• ASCO Update, GU Malignancies 
  9/1/2008
• Colon cancer and Prostate Cancer, Review of Colon Cancer and Prostate Cancer 
  Rochester, MN - 4/1/2008
• Testicular Cancer. In depth review of testicular cancer. 
  Rochester, MN - 2/1/2008
• Renal Cell Carcinoma 
  Amelia Island, FL - 8/1/2007
• GI malignancies. 
• Join now to see all